A citation-based method for searching scientific literature

R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
Times Cited: 242







List of co-cited articles
796 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
599
45

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
39

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
38

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
114
32

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
92
27

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
191
24


Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
99
21

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
20

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
18



Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
235
16

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
16

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
15



Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
14


Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
121
14


Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
Mariëlle S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Am J Med Genet A 2004
48
27

Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families.
J C Coyne, N R Benazon, C G Gaba, K Calzone, B L Weber. J Consult Clin Psychol 2000
92
14

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
13

What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
James C Coyne, Linda Kruus, Melissa Racioppo, Kathleen A Calzone, Katrina Armstrong. Am J Med Genet A 2003
43
30

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
998
13

Stress and genetic testing for disease risk.
A Baum, A L Friedman, S G Zakowski. Health Psychol 1997
96
12

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Tammy M Beran, Annette L Stanton, Lorna Kwan, Joyce Seldon, Julienne E Bower, Andrea Vodermaier, Patricia A Ganz. Ann Behav Med 2008
52
23


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
11

Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
175
11

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Jeffrey R Botkin, Ken R Smith, Robert T Croyle, Bonnie J Baty, Jean E Wylie, Debra Dutson, Anna Chan, Heidi A Hamann, Caryn Lerman, Jamie McDonald,[...]. Am J Med Genet A 2003
154
11

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
262
11

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
10

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Valérie Bonadona, Pierre Saltel, Françoise Desseigne, Hervé Mignotte, Jean-Christophe Saurin, Qing Wang, Olga Sinilnikova, Sophie Giraud, Gilles Freyer, Henri Plauchu,[...]. Cancer Epidemiol Biomarkers Prev 2002
66
15

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
184
10

Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
175
10


One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
127
10


A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
10

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
430
9


The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
M Watson, S Lloyd, J Davidson, L Meyer, R Eeles, S Ebbs, V Murday. Br J Cancer 1999
182
9

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
183
9

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
426
9


Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
B Meiser, V Collins, R Warren, C Gaff, D J B St John, M-A Young, K Harrop, J Brown, J Halliday. Clin Genet 2004
62
14

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
697
9

Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Ellen R Gritz, Susan K Peterson, Sally W Vernon, Salma K Marani, Walter F Baile, Beatty G Watts, Christopher I Amos, Marsha L Frazier, Patrick M Lynch. J Clin Oncol 2005
86
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.